Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.

Prof. Dr. med. Udo Bonnet

Funktionen

  • Nebenberuflich Lehrende/r, Klinik für Psychiatrie und Psychotherapie

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Bonnet, Udo; Kuhn, Jens
    Antidepressants can help to prevent and manage long COVID depression, anxiety, brain fog and fatigue
    In: European Archives of Psychiatry and Clinical Neuroscience, Jg. 275, 2025, Nr. 1, S. 273 – 274
    DOI (Open Access)
  • Bonnet, Udo; Scherbaum, Norbert; Juckel, Georg; Bschor, Tom
    Are Intravenous Subnarcotic Ketamine Infusions as an Adjunct Treatment for Treatment-Resistant Depression Ready to be Recommended in European Guidelines?
    In: Pharmacopsychiatry, Jg. 58, 2025, Nr. 5, S. 242 – 244
    DOI
  • Bonnet, Udo
    Das Cannabinoid Hyperemesis Syndrom : Ein Scoping Review
    In: Fortschritte der Neurologie - Psychiatrie (FDN), 2025, in press
    DOI
  • Bonnet, Udo
    Das Cannabinoid-Hyperemesis-Syndrom  : Ein narratives Review
    In: Der Nervenarzt, 2025, in press
    DOI (Open Access)
  • Lieb, Bodo; De Vries, Alessa; Bonnet, Udo; Lissa, Kyra; Rasch, Johanna S.; Specka, Michael; Scherbaum, Norbert
    Der Einfluss eines altersspezifischen Behandlungssettings auf den Erfolg einer qualifizierten Entzugsbehandlung bei älteren Patienten mit substanzbezogenen Störungen
    In: Psychiatrische Praxis, Jg. 52, 2025, Nr. 05, S. 251 – 257
    DOI
  • Scherbaum, Norbert; Specka, Michael; Wodarz, N.; Bonnet, Udo; Roser, Patrik
    Die Diamorphinbehandlung Opioidabhängiger : zur Novellierung der Indikationskriterien nach Betäubungsmittel-Verschreibungsverordnung
    In: Der Nervenarzt, 2025, in press
    DOI (Open Access)
  • Scherbaum, Norbert; Bonnet, Udo
    Drogenbezogene Probleme im psychiatrischen Konsildienst
    In: Der Nervenarzt, Jg. 96, 2025, Nr. 4, S. 336 – 341
    DOI (Open Access)
  • Rabl, Josef; Specka, Michael; Bonnet, Udo; Irtürk, Özge; Schifano, Fabrizio; Scherbaum, Norbert
    Evaluation of E-Cigarette Use in Opioid-Dependent Patients in Maintenance Treatment
    In: Pharmacopsychiatry, Jg. 58, 2025, Nr. 2, S. 88 – 94
    DOI
  • Bonnet, Udo; Juckel, Georg
    News on the Role of Antidepressants in and for COVID-19 and Long COVID
    In: Pharmacopsychiatry, Jg. 58, 2025, Nr. 1, S. 41 – 44
    DOI
  • Bonnet, Udo
    Not only the main streams, but also the tributaries supply the landscape : Antidepressants for the prevention of severe COVID-19
    In: European Archives of Psychiatry and Clinical Neuroscience, 2025, in press
    DOI (Open Access)
  • Rohlfing, Nico; Pum, Martin; Bonnet, Udo; Kölkebeck, Katja; Scherbaum, Norbert
    Psychotherapy Research Domain Criteria : Functional mechanisms of treatment and a basic theory of the mind
    In: Frontiers in Psychiatry, Jg. 16, 2025, 1549976
    DOI, Online Volltext (Open Access)
  • Bonnet, Udo; Kuhn, Jens
    Serotonin deficiency and psychiatric long COVID: both caused specifically by the virus itself or an adaptive general stress response?
    In: European Archives of Psychiatry and Clinical Neuroscience, Jg. 275, 2025, Nr. 1, S. 271 – 272
    DOI
  • Kanti, Ann-Kristin; Specka, Michael; Scherbaum, Norbert; Bonnet, Udo
    Vergleichende Risiko/Nutzen-Analyse verschiedener psychotroper Substanzen aus der Perspektive deutscher Drogenkonsumenten und Suchtmediziner : Ein Beitrag für die Psychoedukationsarbeit mit Abhängigkeitserkrankten und Restriktions-/Legalisierungsdebatten
    In: Fortschritte der Neurologie - Psychiatrie (FDN), Jg. 93, 2025, Nr. 1-2, S. 19 – 35
    DOI
  • Bonnet, Udo; Juckel, Georg; Kuhn, Jens
    Antidepressants for prevention of severe COVID-19, Long COVID and outlook for other viral diseases
    In: Frontiers in Medicine, Jg. 11, 2024, 1305184
    DOI (Open Access)
  • Bonnet, Udo
    Cannabis Hyperemesis Syndrome Recovers Completely When the Use of Cannabis or Synthetic Cannabinoids Is Permanently Discontinued : Cyclic Vomiting Syndrome Does Not
    In: Gastroenterology, Jg. 167, 2024, Nr. 5, S. 1054 – 1055
    DOI (Open Access)
  • Roser, Patrik; Specka, Michael; Bonnet, Udo; Kuhlmann, Thomas; Kühnhold, Stefan; Steinert, Renate; Zeiske, Benita; Deimel, Daniel; Scherbaum, Norbert
    Consumption patterns before and during the COVID-19 pandemic among patients admitted to inpatient drug detoxification treatment : Results of two cross-sectional surveys from 2018 and 2021
    In: Frontiers in Psychiatry, Jg. 15, 2024, 1467144
    DOI, Online Volltext (Open Access)
  • Bonnet, Udo; Juckel, Georg
    Die Bedeutung von Antidepressiva bei COVID-19 und Long-COVID : Ein Scoping-Review Update
    In: Fortschritte der Neurologie - Psychiatrie (FDN), 2024
    DOI
  • Scherbaum, Norbert; Bonnet, Udo
    Die Herausforderungen für die psychiatrische Versorgung durch synthetische Drogen
    In: Der Nervenarzt, Jg. 95, 2024, Nr. 9, S. 818 – 823
    DOI
  • Specka, Michael; Bonnet, Udo; Schmidberg, Lisa; Wichmann, Julian; Keller, Martin; Scholze, Christian; Scherbaum, Norbert
    Effectiveness of Medical Cannabis for the Treatment of Depression : A Naturalistic Outpatient Study
    In: Pharmacopsychiatry, Jg. 57, 2024, Nr. 02, S. 61 – 68
    DOI
  • Claus, Benedikt Bernd; Scherbaum, Norbert; Specka, Michael; Roser, Patrik; Bonnet, Udo
    Exploratory Growth Mixture Modeling of Cannabis-Withdrawal Syndrome Trajectories of Adult Pure Cannabis Dependents During Detoxification : Two Subtypes?
    In: Journal of Psychoactive Drugs, Jg. 56, 2024, Nr. 4, S. 551 – 562
    DOI
  • Bonnet, Udo
    Gabapentinoids : Considerations on their contextual harmfulness and psychological dependence potential
    In: International Journal of Drug Policy, Jg. 134, 2024, 104655
    DOI
  • Roser, Patrik; Brunstein, Mona; Specka, Michael; Timm, Jörg; Kühnhold, Stefan; Schifano, Fabrizio; Bonnet, Udo; Scherbaum, Norbert
    Knowledge of, and attitude towards, the treatment of hepatitis C in people who inject drugs
    In: Harm Reduction Journal, Jg. 21, 2024, Nr. 1, 160
    DOI (Open Access)
  • Wellensiek, Julian; Specka, Michael; Just, Johannes; Banger, Markus; Bonnet, Udo; Scherbaum, Norbert
    Patient Perspectives on Pharmacotherapy of Alcohol Dependence
    In: Pharmacopsychiatry, Jg. 57, 2024, Nr. 1, S. 21 – 29
    DOI
  • Bonnet, Udo; Scherbaum, Norbert; Schaper, Andreas; Soyka, Michael
    Phenibutan-an Illegal Food Supplement With Psychotropic Effects and Health Risks
    In: Deutsches Ärzteblatt International, Jg. 121, 2024, Nr. 7, S. 222 – 227
    DOI (Open Access)
  • Kurzhals, Simon; Schäfer, Martin; Bonnet, Udo; Isbruch, Katrin; Kühnhold, Stefan; Timm, Jörg; Specka, Michael; Scherbaum, Norbert
    SARS-CoV-2-Infection in People Addicted to Illegal Drugs : Is There a Protective Effect of Opioid Maintenance Treatment?
    In: Pharmacopsychiatry, Jg. 57, 2024, Nr. 5, S. 255 – 260
    DOI
  • Bonnet, Udo
    Ten years of maintenance treatment of severe melancholic depression in an adult woman including discontinuation experiences : Beneficial effects of high-dose venlafaxine compared to other antidepressants and cognitive behavioral therapy
    In: Fortschritte der Neurologie - Psychiatrie (FDN), 2024, in press
    DOI
  • Claus, Benedikt B.; Wager, Julia; Bonnet, Udo
    clinicalsignificance : Clinical Significance Analyses of Intervention Studies in R
    In: Journal of Statistical Software, Jg. 111, 2024, Nr. 1, S. 1 – 39
    DOI (Open Access)
  • Bonnet, Udo; Specka, Michael; Roser, Patrik; Scherbaum, Norbert
    Cannabis use, abuse and dependence during the COVID-19 pandemic : A scoping review
    In: Journal of Neural Transmission, Jg. 130, 2023, Nr. 1, S. 7 – 18
    DOI (Open Access)
  • Bonnet, Udo; Pohlmann, Laura; McAnally, Heath; Claus, Benedikt Bernd
    Further evidence of relationship between thiamine blood level and cognition in chronic alcohol-dependent adults : Prospective Pilot Study of an inpatient detoxification with oral supplementation protocol
    In: Alcohol, Jg. 110, 2023, S. 23 – 31
    DOI
  • Bonnet, Udo
    Gabapentinoide - Desensitisierer und GABA-Mimetika Mechanismen, Hypothesen und Herausforderungen bezüglich einer klinisch noch nicht genügend erschlossenen gut verträglichen Substanzklasse
    In: Psychopharmakotherapie, 2023, Nr. 9, S. 199 – 205
  • Bonnet, Udo; McAnally, Heath
    Gabapentinoids: condemned without sufficient evidence?
    In: The Lancet Regional Health - Europe, Jg. 28, 2023, 100629
    DOI (Open Access)
  • Richter, Lisa Emily; Machleit-Ebner, Annika; Scherbaum, Norbert; Bonnet, Udo
    How Effective is a Web-Based Mental Health Intervention (Deprexis) in the Treatment of Moderate and Major Depressive Disorders when started during Routine Psychiatric Inpatient Treatment as an Adjunct Therapy? : A Pragmatic Parallel-Group Randomized Controlled Trial
    In: Fortschritte der Neurologie - Psychiatrie (FDN), Jg. 91, 2023, Nr. 07/08, S. 297 – 310
    DOI
  • Bonnet, Udo
    Initiation of antidepressants in patients infected with SARS-COV-2 : Don't forget Caution for “Paradoxical” Anxiety/Jitteriness syndrome - Commentary: Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution
    In: Frontiers in Psychiatry, Jg. 14, 2023, 1095244
    DOI, Online Volltext (Open Access)
  • Specka, Michael; Kröckert, Tobias; Trilling, Mirko; Bonnet, Udo; Schifano, Fabrizio; Scherbaum, Norbert
    Opiate maintenance patients’ attitudes and self-reported adherence to protective measures against SARS-CoV-2 infections
    In: Frontiers in Psychiatry, Jg. 14, 2023, 1254053
    DOI, Online Volltext (Open Access)
  • Bonnet, Udo; Kanti, Ann-Kristin; Scherbaum, Norbert; Specka, Michael
    The Role of Gabapentinoids in the Substance Use Pattern of Adult Germans Seeking Inpatient Detoxification Treatment : A Pilot Study
    In: Journal of Psychoactive Drugs, Jg. 55, 2023, Nr. 1, S. 102 – 111
    DOI
  • Bschor, T.; Bonnet, Udo; Pitzer, M.; Baethge, C.; Lieb, K.; Gertz, H.-J.; Müller-Oerlinghausen, B.
    Absetzen von Antidepressiva – Absetzsymptome und Rebound-Effekte : Übersicht und praktische Empfehlungen
    In: Der Nervenarzt, Jg. 93, 2022, Nr. 1, S. 93 – 101
    DOI
  • Bonnet, Udo; Specka, Michael; Soyka, Michael; Alberti, Thomas; Bender, Stefan; Hilger, Jörg; Hillemacher, Thomas; Kuhlmann, Thomas; Kuhn, Jens; Lüdecke, Christel; Reimer, Jens; Schneider, Udo; Schroeder, Welf; Stuppe, Markus; Wiesbeck, Gerhard; Wodarz, Norbert; Scherbaum, Norbert
    Abwägung von Nutzen und Schädlichkeit von berauschenden und schmerzlindernden Substanzen aus der Perspektive von deutschen Suchtmedizinern
    In: Fortschritte der Neurologie - Psychiatrie (FDN), Jg. 90, 2022, Nr. 01/02, S. 19 – 29
    DOI
  • Bonnet, Udo; Juckel, Georg
    COVID-19 Outcomes: Does the Use of Psychotropic Drugs Make a Difference? Accumulating Evidence of a Beneficial Effect of Antidepressants : A Scoping Review
    In: Journal of Clinical Psychopharmacology, Jg. 42, 2022, Nr. 3, S. 284 – 292
    DOI (Open Access)
  • Vuilleumier, Caroline; Scherbaum, Norbert; Bonnet, Udo; Roser, Patrik
    Cannabinoids in the Treatment of Cannabis Use Disorder : Systematic Review of Randomized Controlled Trials
    In: Frontiers in Psychiatry, Jg. 13, 2022, 867878
    DOI, Online Volltext (Open Access)
  • Bonnet, Udo
    Cannabis-Related Cyclic/Episodic Hyperemesis Conditions : From Suspected to Definitive Cannabinoid Hyperemesis Syndrome
    In: Medical Principles and Practice, Jg. 31, 2022, Nr. 5, S. 497 – 498
    DOI (Open Access)
  • Bonnet, Udo; Specka, Michael; Kanti, Ann-Kristin; Scherbaum, Norbert
    Differences between users’ and addiction medicine experts’ harm and benefit assessments of licit and illicit psychoactive drugs : Input for psychoeducation and legalization/restriction debates
    In: Frontiers in Psychiatry, Jg. 13, 2022, 1041762
    DOI (Open Access)
  • Müller, Gregor; Sachse, Rainer; Langer, Katja; Claus, Benedikt Bernd; Bonnet, Udo
    Evaluation der Wirksamkeit der klärungsorientierten Psychotherapie bei Personen mit einer narzisstischen Persönlichkeitsstörung nach DSM-IV-eine naturalistische Längsschnittstudie mit prä-post Design
    In: Fortschritte der Neurologie - Psychiatrie (FDN), Jg. 90, 2022, Nr. 9, S. 396 – 405
    DOI
  • Bonnet, Udo; Auwärter, Volker; Scherbaum, Norbert
    Gabapentinoid-related deaths : An alarming global trend or just a special challenge within the long tail of the giant opioid epidemic?
    In: The Lancet Regional Health: Americas, Jg. 11, 2022, 100309
    DOI (Open Access)
  • Bonnet, Udo; McAnally, Heath B.
    How prevalent and severe is addiction on GABAmimetic drugs in an elderly German general hospital population? : Focus on gabapentinoids, benzodiazepines, and z-hypnotic drugs
    In: Human Psychopharmacology: Clinical and Experimental, Jg. 37, 2022, Nr. 3, S. e2822
    DOI (Open Access)
  • Bonnet, Udo; Claus, Benediktbernd; Schaefer, Martin; Kuhn, Jens; Nyhuis, Peter; Scherbaum, Norbert; Brüne, Martin; Wakili, Velat; Juckel, Georg
    Impact of Psychiatric and Related Somatic Medications on the Duration and Severity of COVID-19 : A Retrospective Explorative Multi-center Study from the German Metropolitan Ruhr-area
    In: Pharmacopsychiatry, Jg. 55, 2022, Nr. 01, S. 30 – 39
    DOI
  • Bonnet, Udo; Knierim, Uwe; Ronge, Regine; Jahn, Jürgen
    Late-Onset Polyserositis Emerging During Long-Term Clozapine Treatment and Persisting After Clozapine Discontinuation
    In: Journal of Clinical Psychopharmacology, Jg. 42, 2022, Nr. 1, S. 106 – 107
    DOI
  • Bonnet, Udo; Borda, Thorsten; Scherbaum, Norbert; Specka, Michael
    Long-Term Frequent Cannabis Use and Related Serum Cannabinoid Levels Are Not Associated with Kidney Dysfunction
    In: Cannabis and Cannabinoid Research, Jg. 7, 2022, Nr. 5, S. 670 – 676
    DOI, Online Volltext (Open Access)
  • Specka, Michael; Kuhlmann, Thomas; Bonnet, Udo; Sawazki, Jürgen; Schaaf, Luzia; Kühnhold, Stefan; Steinert, Renate; Grigoleit, Torsten; Eich, Helmut; Zeiske, Benita; Niedersteberg, Antje; Steiner, Katharina; Schifano, Fabrizio; Scherbaum, Norbert
    Novel Synthetic Opioids (NSO) Use in Opioid Dependents Entering Detoxification Treatment
    In: Frontiers in Psychiatry, Jg. 13, 2022, 868346
    DOI, Online Volltext (Open Access)
  • Habermeyer, Benedikt; Lay, Barbara; Scherbaum, Norbert; Bonnet, Udo; Roser, Patrik
    Referral to aftercare following inpatient withdrawal treatment and readmission : retrospective chart review of patients with substance use disorders
    In: Swiss Medical Weekly, Jg. 152, 2022, w30213
    DOI (Open Access)
  • Rohlfing, Nico; Bonnet, Udo; Tendolkar, Indira; Hinney, Anke; Scherbaum, Norbert
    Subjective reward processing and catechol-O- methyltransferase Val158Met polymorphism as potential research domain criteria in addiction : A pilot study
    In: Frontiers in Psychiatry, Jg. 13, 2022, 992657
    DOI, Online Volltext (Open Access)
  • Claus, Benedikt B.; Bonnet, Udo
    Wirksamkeit einer zusätzlichen psychotherapeutischen Kurzintervention (entwickelt zur Verstärkung des Placebo-Effektes (PE+) und Abschwächung des Nocebo-Effektes (NE−) von Antidepressiva) bei der stationär-psychiatrischen Behandlung von moderaten/schweren unipolaren Depressionen von Erwachsenen
    In: Die Psychotherapie, Jg. 67, 2022, Nr. 4, S. 344 – 346
    DOI
  • Bonnet, Udo; Juckel, Georg; Scherbaum, Norbert; Schaefer, Martin; Kis, Bernhard; Cohen, Simon; Kuhn, Jens
    Are Persons Treated with Antidepressants and/or Antipsychotics Possibly Better Protected against Severe COVID 19?
    In: Pharmacopsychiatry, Jg. 54, 2021, Nr. 3, S. 142 – 143
    DOI
  • Scherbaum, Norbert; Bonnet, Udo; Hafermann, Henning; Schifano, Fabrizio; Bender, Stefan; Grigoleit, Torsten; Kuhn, Jens; Nyhuis, Peter; Preuss, Ulrich W.; Reymann, Gerhard; Schneider, Udo; Shibata, Jo; Specka, Michael
    Availability of Illegal Drugs During the COVID-19 Pandemic in Western Germany
    In: Frontiers in Psychiatry, Jg. 12, 2021, 648273
    DOI (Open Access)
  • Bonnet, Udo; McAnally, Heath; Scherbaum, Norbert
    Comment on “Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update”
    In: Drugs, Jg. 81, 2021, Nr. 5, S. 611 – 614
    DOI (Open Access)
  • McAnally, Heath; Bonnet, Udo; Kaye, Alan D.
    Correction to: Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth
    In: Pain and Therapy, Jg. 10, 2021, Nr. 1, S. 763 – 764
    DOI (Open Access)
  • Specka, Michael; Kuhlmann, Thomas; Sawazki, Jürgen; Bonnet, Udo; Steinert, Renate; Cybulska-Rycicki, Monika; Eich, Helmut; Zeiske, Benita; Niedersteberg, Antje; Schaaf, Luzia; Scherbaum, Norbert
    Corrigendum: Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment
    In: Frontiers in Psychiatry, Jg. 12, 2021, 681542
    DOI, Online Volltext (Open Access)
  • Marschollek, Laura; Bonnet, Udo
    Do patients’ resilience and subjective illness representation predict the outcome of a routine inpatient treatment program of major depressive disorder?
    In: European Archives of Psychiatry and Clinical Neuroscience, Jg. 271, 2021, Nr. 7, S. 1309 – 1317
    DOI (Open Access)
  • Scherbaum, Norbert; Seiffert, Friedrich; Schifano, Fabrizio; Specka, Michael; Bonnet, Udo; Bender, Stefan
    High lifetime, but low current, prevalence of new psychotropic substances (NPS) use in German drug detoxification treatment young inpatients
    In: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Jg. 111, 2021, 110144
    DOI (Open Access)
  • Scherbaum, Norbert; Mikoteit, Thomas; Witkowski, Lilia; Bonnet, Udo; Specka, Michael; Schifano, Fabrizio; Lieb, Bodo
    New access routes to undertreated populations : How do problem substance users recruited from an unemployment office differ from detoxification treatment inpatients?
    In: International Journal of Environmental Research and Public Health = IJERPH, Jg. 18, 2021, Nr. 24, 13014
    DOI, Online Volltext (Open Access)
  • Chiappini, Stefania; Schifano, Fabrizio; Martinotti, Giovanni; Strasser, Johanna C.; Bonnet, Udo; Scherbaum, Norbert
    Opioid painkiller dependence in a sample of elderly medical inpatients
    In: Psychogeriatrics, 2021, in press
    DOI (Open Access)
  • McAnally, Heath B.; Bonnet, Udo
    Response to Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth”
    In: Pain and Therapy, Jg. 10, 2021, Nr. 1, S. 757 – 762
    DOI (Open Access)
  • Bonnet, Udo
    Cannabis hyperemesis syndrome : A specific cannabis-related disorder?
    In: Neurogastroenterology and Motility, Jg. 32, 2020, Nr. 1, S. e13723
    DOI
  • Claus, Benedikt Bernd; Scherbaum, Norbert; Bonnet, Udo
    Effectiveness of an Adjunctive Psychotherapeutic Intervention Developed for Enhancing the Placebo Effect of Antidepressants Used within an Inpatient-Treatment Program of Major Depression : A Pragmatic Parallel-Group, Randomized Controlled Trial
    In: Psychotherapy and Psychosomatics, Jg. 89, 2020, Nr. 4, S. 258 – 260
    DOI
  • McAnally, Heath; Bonnet, Udo; Kaye, Alan D.
    Gabapentinoid Benefit and Risk Stratification : Mechanisms Over Myth
    In: Pain and Therapy, Jg. 9, 2020, Nr. 2, S. 441 – 452
    DOI (Open Access)
  • Claus, Benedikt Bernd; Specka, Michael; McAnally, Heath; Scherbaum, Norbert; Schifano, Fabrizio; Bonnet, Udo
    Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor?
    In: Frontiers in Psychiatry, Jg. 11, 2020, S. 598150
    DOI, Online Volltext (Open Access)
  • Specka, Michael; Kuhlmann, Thomas; Sawazki, Jürgen; Bonnet, Udo; Steinert, Renate; Cybulska-Rycicki, Monika; Eich, Helmut; Zeiske, Benita; Niedersteberg, Antje; Schaaf, Luzia; Scherbaum, Norbert
    Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment
    In: Frontiers in Psychiatry, Jg. 11, 2020, S. 569
    DOI, Online Volltext (Open Access)
  • Bonnet, Udo; Specka, Michael; Soyka, Michael; Alberti, Thomas; Bender, Stefan; Grigoleit, Torsten; Hermle, Leopold; Hilger, Jörg; Hillemacher, Thomas; Kuhlmann, Thomas; Kuhn, Jens; Luckhaus, Christian; Lüdecke, Christel; Reimer, Jens; Schneider, Udo; Schroeder, Welf; Stuppe, Markus; Wiesbeck, Gerhard A.; Wodarz, Norbert; McAnally, Heath; Scherbaum, Norbert
    Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others : A Perspective of German Addiction Medicine Experts
    In: Frontiers in Psychiatry, Jg. 11, 2020, S. 592199
    DOI, Online Volltext (Open Access)
  • Bonnet, Udo; Wiemann, Martin
    Topiramate decelerates bicarbonate-driven acid-elimination of human neocortical neurons : Strategic significance for its antiepileptic, antimigraine and neuroprotective properties
    In: CNS & Neurological Disorders - Drug Targets, Jg. 19, 2020, Nr. 4, S. 264 – 275
    DOI
  • Scherbaum, Norbert; Holzbach, Rüdiger; Stammen, Gunnar; Kirchof, Ute; Bonnet, Udo
    Very Low Frequency of Drug Therapy of Alcohol Dependence in Germany - Analysis of Data of A Statutory Health Insurance
    In: Pharmacopsychiatry, Jg. 53, 2020, Nr. 1, S. 37 – 39
    DOI
  • Bonnet, Udo
    Ein kurzes Essay über die Spiritualität von Placebo aus (evolutionär) psychiatrischer Sicht
    In: Fortschritte der Neurologie - Psychiatrie (FDN), Jg. 87, 2019, Nr. 7, S. 347 – 354
    DOI
  • Bonnet, Udo; Bingmann, Dieter; Speckmann, Erwin-Josef; Wiemann, Martin
    Levetiracetam mediates subtle pH-shifts in adult human neocortical pyramidal cells via an inhibition of the bicarbonate-driven neuronal pH-regulation – Implications for excitability and plasticity modulation
    In: Brain Research, Jg. 1710, 2019, S. 146 – 156
    DOI
  • Scherbaum, Norbert; Bonnet, Udo
    Neurobiologie der Opioidabhängigkeit
    In: Der Anaesthesist, Jg. 68, 2019, Nr. 3, S. 179 – 190
    DOI
  • Scherbaum, Norbert; Bonnet, Udo
    Neurobiologie der Opioidabhängigkeit
    In: Zentralblatt für Arbeitsmedizin, Arbeitsschutz und Ergonomie, Jg. 69, 2019, Nr. 2, S. 105 – 116
    DOI
  • Bonnet, Udo; Strasser, Johanna Cristina; Scherbaum, Norbert
    Screening for physical and behavioral dependence on non-opioid analgesics in a German elderly hospital population
    In: Addictive Behaviors, Jg. 90, 2019, S. 265 – 271
    DOI
  • Bonnet, Udo
    The sour side of vitamin C might mediate neuroprotective, anticonvulsive and antidepressant-like effects
    In: Medical Hypotheses, Jg. 131, 2019, 109320
    DOI
  • Bonnet, Udo; Taha, Sarya; Stuehler, Luidmilla; Knierim, Uwe
    The transition from vivid dreams over floccillations and visual hallucinations to complete delirium in a geriatric patient at the dawn of Alzheimer's dementia : beneficial role of rivastigmine
    In: Psychogeriatrics, Jg. 19, 2019, Nr. 4, S. 404 – 406
    DOI
  • Bonnet, Udo; Knierim, Uwe
    Venlafaxine ER-related strong suicidal intent in an adult with lithium-treated severe major depression : a phenomenological proximity with other paradoxical reactions of psychoactive agents
    In: Psychiatria Danubina, Jg. 31, 2019, Nr. 3, S. 366 – 368
    DOI, Online Volltext (Open Access)
  • Bonnet, Udo; Bingmann, Dieter; Speckmann, Erwin-Josef; Wiemann, Martin
    Aging is associated with a mild acidification in neocortical human neurons in vitro
    In: Journal of Neural Transmission, Jg. 125, 2018, Nr. 10, S. 1495 – 1501
    DOI
  • Nyhuis, Peter W.; Niederhofer, Eva; Scherbaum, Norbert; Schifano, Fabrizio; Bonnet, Udo; Dembski, Nikolai; Niederhofer, Anna; Specka, Michael; Tenbergen, Meike
    Effectiveness of Psychoanalytic-Interactional Group Therapy vs. Behavioral Group Therapy in Routine Outpatient Treatment of Alcohol-Dependent Patients
    In: Substance Use & Misuse, Jg. 53, 2018, Nr. 3, S. 426 – 431
    DOI
  • Bonnet, Udo; Canbay, Aliekber; Specka, M.; Scherbaum, Norbert
    Long-Term Heavy Recreational Cannabis Use and Serum Delta-9-Tetrahydrocannabinol Levels are not Associated with an Impaired Liver Function in Cannabis Dependents
    In: Journal of Psychoactive Drugs, Jg. 50, 2018, Nr. 4, S. 355 – 360
    DOI
  • Scherbaum, Norbert; Bonnet, Udo
    Neurobiologie der Opioidabhängigkeit
    In: Der Schmerz, Jg. 32, 2018, Nr. 6, S. 483 – 494
    DOI
  • Bonnet, Udo; Richter, Emily-Lisa; Isbruch, Katrin; Scherbaum, Norbert
    On the addictive power of gabapentinoids : A mini-review
    In: Psychiatria Danubina, Jg. 30, 2018, Nr. 2, S. 142 – 149
  • Scherbaum, Norbert; Timm, Jörg; Richter, F.; Bonnet, Udo; Bombeck, J.; Lajos, S.; Specka, M.
    Outcome of a hepatitis B vaccination program for clients of a drug consumption facility
    In: Journal of Clinical Virology, Jg. 106, 2018, S. 28 – 32
    DOI
  • Bonnet, Udo; Bingmann, Dieter; Speckmann, Erwin-Josef; Wiemann, Martin
    Small intraneuronal acidification via short-chain monocarboxylates : First evidence of an inhibitory action on over-excited human neocortical neurons
    In: Life Sciences (Including Pharmacology Letters Online), Jg. 204, 2018, S. 65 – 70
    DOI
  • Bonnet, Udo; Scherbaum, Norbert
    Über das Abhängigkeitspotential von Gabapentinoiden
    In: Fortschritte der Neurologie - Psychiatrie (FDN), Jg. 86, 2018, Nr. 2, S. 82 – 105
    DOI
  • Bonnet, Udo; Ringel, Peter
    Black hairy tongue associated with lorazepam treatment of a male smoker with major depression
    In: Journal of Clinical Psychopharmacology, Jg. 37, 2017, Nr. 2, S. 261 – 263
    DOI
  • Dirks, Henrike; Esser, Stefan; Brockmeyer, Norbert; Bonnet, Udo; Schifano, Fabrizio; Scherbaum, Norbert
    Dramatic changes over time of methamphetamine intake in a German, HIV-positive, sample of men who have sex with men (MSM)
    In: Pharmacopsychiatry, Jg. 50, 2017, Nr. 3, S. 123 – 124
    DOI
  • Bonnet, Udo; Scherbaum, Norbert
    How addictive are gabapentin and pregabalin? : A systematic review
    In: European Neuropsychopharmacology, Jg. 27, 2017, Nr. 12, S. 1185 – 1215
    DOI
  • Bonnet, Udo
    How much alcohol is in ketamine's antidepressant action?
    In: Life Sciences (Including Pharmacology Letters Online), Jg. 168, 2017, S. 54 – 57
    DOI
  • Scherbaum, Norbert; Schifano, F.; Bonnet, Udo
    New Psychoactive Substances (NPS) - A Challenge for the Addiction Treatment Services
    In: Pharmacopsychiatry, Jg. 50, 2017, Nr. 3, S. 116 – 122
    DOI (Open Access)
  • Bonnet, Udo; Preuss, Ulrich W
    The cannabis withdrawal syndrome : current insights
    In: Substance Abuse and Rehabilitation, Jg. 8, 2017, S. 9 – 37
    DOI (Open Access)
  • Bonnet, Udo
    Abrupt Quitting of Long-term Heavy Recreational Cannabis Use is Not Followed by Significant Changes in Blood Pressure and Heart Rate
    In: Pharmacopsychiatry, Jg. 49, 2016, Nr. 1, S. 23 – 25
    DOI
  • Bonnet, Udo
    An overlooked victim of cannabis : Losing several years of well-being and inches of jejunum on the way to unravel her hyperemesis enigma
    In: Clinical Neuropharmacology, Jg. 39, 2016, Nr. 1, S. 53 – 54
    DOI
  • Bonnet, Udo; Scherbaum, Norbert
    Comment: Gabapentin : Abuse, Dependence, and Withdrawal
    In: Annals of Pharmacotherapy, Jg. 50, 2016, Nr. 8, S. 691
    DOI
  • Bonnet, Udo; Selle, Claudia; Kuhlmann, Ralf
    Delirious Mania Associated with Autoimmune Gastrothyroidal Syndrome of a Mid-Life Female: The Role of Hashimoto Encephalopathy and a 3-Year Follow-Up including Serum Autoantibody Levels
    In: Case reports in psychiatry, Jg. 2016, 2016, 4168050
    DOI (Open Access)
  • Bonnet, Udo; Selle, Claudia; Isbruch, Kathrin
    Erratum to : Recurrent purpura due to alcohol-related Schamberg's disease and its association with serum immunoglobulins: A longitudinal observation of a heavy drinker
    In: Journal of Medical Case Reports, Jg. 10, 2016, Nr. 1, S. 1 – 1
    DOI
  • Bonnet, Udo; Specka, Michael; Scherbaum, Norbert
    Häufiger Konsum von nicht-medizinischem Cannabis : Gesundheitliche Folgen und Wirkung der Entzugsbehandlung
    In: Deutsche Medizinische Wochenschrift - DMW, Jg. 141, 2016, Nr. 2, S. 126 – 131
    DOI
  • Bonnet, Udo
    Legalisierung von Cannabis : Zum laufenden experiment mit der Bevölkerung
    In: Sucht, Jg. 62, 2016, Nr. 3, S. 181 – 183
    DOI
  • Bonnet, Udo; Selle, Claudia; Isbruch, Katrin
    Recurrent purpura due to alcohol-related Schamberg's disease and its association with serum immunoglobulins : a longitudinal observation of a heavy drinker
    In: Journal of Medical Case Reports, Jg. 10, 2016, Nr. 1, S. 301
    DOI (Open Access)
  • Cossmann, Johanna Christina; Bonnet, Udo; Scherbaum, Norbert
    Substance Addiction in Old Age : A Cross-Sectional Study in a German Hospital
    In: GeroPsych: The Journal of Gerontopsychology and Geriatric Psychiatry, Jg. 29, 2016, Nr. 1, S. 17 – 27
    DOI
  • Langrock, C.; Bonnet, Udo
    Zur Ergebnisqualität der allgemeinpsychiatrischen offenstationären Krankenhausbehandlung auf der Mesoebene – eine prospektive Studie aus einem urbanen Allgemeinkrankenhaus
    In: Fortschritte der Neurologie - Psychiatrie (FDN), Jg. 84, 2016, Nr. 6, S. 354 – 362
    DOI
  • Bonnet, Udo; Borda, Thorsten; Scherbaum, Norbert; Specka, Michael
    Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification (Part II) : psychiatric complaints and their relation to delta-9-tetrahydrocannabinol and its metabolites in serum
    In: Drug and Alcohol Dependence, Jg. 155, 2015, S. 302 – 306
    DOI
  • Bonnet, Udo
    Long-Term Ketamine Self-Injections in Major Depressive Disorder : Focus on Tolerance in Ketamine's Antidepressant Response and the Development of Ketamine Addiction
    In: Journal of Psychoactive Drugs, Jg. 47, 2015, Nr. 4, S. 276 – 285
    DOI
  • Hoch, Eva; Bonnet, Udo; Thomasius, Rainer; Ganzer, Florian; Havemann-Reinecke, Ursula; Preuss, Ulrich W.
    Risks Associated With the Non-Medicinal Use of Cannabis
    In: Deutsches Ärzteblatt International, Jg. 112, 2015, Nr. 16, S. 271 – 278
    DOI
  • Bonnet, Udo; Taazimi, Behnaz; Montag, Martin; Ronge, Regine; Gespers, Holger; Kuhlmann, Ralf; Grabbe, Dieter; Jahn, Jürgen
    Severe acute pancreatitis, neuroleptic malignant syndrome and grand mal seizures associated with elevated amisulpride and low clozapine serum levels
    In: Psychiatria Danubina, Jg. 27, 2015, Nr. 4, S. 424 – 425
    Online Volltext
  • Bonnet, Udo; Mahler, H.
    Synthetische Cannabinoide : Verbreitung, Suchtbiologie & aktuelle Perspektive der persönlichen Gesundheitsgefährdung
    In: Fortschritte der Neurologie - Psychiatrie (FDN), Jg. 83, 2015, Nr. 4, S. 221 – 231
    DOI
  • Bonnet, Udo; Kuhlmann, R.; Nefedev, A.; Richter, L.E.; Khalil-Boutros, Y.; Steinkamp, I.; Gall, H.; Schubert, M.; Ossowski, A.
    Zur Differenzialdiagnose des quälenden psychogenen chronischen Hustens : neuropathischer Larynx irritable – Gabapentin als Antitussivum
    In: Fortschritte der Neurologie - Psychiatrie (FDN), Jg. 83, 2015, Nr. 10, S. 568 – 577
    DOI
  • Bonnet, Udo; Specka, M; Stratmann, U; Ochwadt, R; Scherbaum, Norbert
    Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification : cannabis withdrawal syndrome and its correlation with delta-9-tetrahydrocannabinol and -metabolites in serum
    In: Drug and Alcohol Dependence, Jg. 143, 2014, S. 189 – 197
    DOI
  • Bonnet, Udo; Khalil-Boutros, Y
    Acute Bilateral Parotitis Occurring during Venlafaxine Titration in an Adolescent Female with Major Depression
    In: Pharmacopsychiatry, Jg. 47, 2014, Nr. 1, S. 36 – 38
    DOI
  • Bonnet, Udo
    Dekompensierter chronischer Tinnitus und Hochdosis-Benzodiazepinabhängigkeit : Zwischen Skylla und Charybdis
    In: Der Nervenarzt, Jg. 85, 2014, Nr. 7, S. 865 – 869
    DOI
  • Bonnet, Udo; Taazimi, Behnaz; Borda, Thorsten; Grabbe, Heinz-Dieter
    Improvement of a woman's alcohol-related dementia via off-label memantine treatment : a 16-month clinical observation
    In: Annals of Pharmacotherapy, Jg. 48, 2014, Nr. 10, S. 1371 – 1375
    DOI
  • Bonnet, Udo; Taazimi, Behnaz; Grabbe, Heinz-Dieter
    Pregabalin-Related Hypertriglyceridemia
    In: Psychosomatics, Jg. 55, 2014, Nr. 6, S. 723 – 728
    DOI, Online Volltext
  • Bonnet, Udo
    Chronic cannabis abuse, delta-9-tetrahydrocannabinol and thyroid function
    In: Pharmacopsychiatry, Jg. 46, 2013, Nr. 1, S. 35 – 36
    DOI
  • Bonnet, Udo; Chang, D.-I.; Scherbaum, Norbert
    Cannabis Hyperemesis Syndrome
    In: Fortschritte der Neurologie - Psychiatrie (FDN), Jg. 80, 2012, Nr. 2, S. 98 – 101
    DOI
  • Bonnet, Udo; Scherbaum, Norbert
    Craving dominates propofol addiction of an affected physician
    In: Journal of Psychoactive Drugs, Jg. 44, 2012, Nr. 2, S. 186 – 190
    DOI
  • Richter, Christoph; Effenberger, Susanne; Bschor, Tom; Bonnet, Udo; Haasen, Christian; Preuss, Ulrich W.; Heinz, Andreas; Förg, Anna; Volkmar, Katharina; Glauner, Till; Schaefer, Martin
    Efficacy and safety of levetiracetam for the prevention of alcohol relapse in recently detoxified alcohol-dependent patients : A randomized trial
    In: Journal of Clinical Psychopharmacology, Jg. 32, 2012, Nr. 4, S. 558 – 562
    DOI
  • Bonnet, Udo; Wiemann, Martin
    Neuropsychopharmaka verändern den intrazellulären pH-Wert von zentralen Neuronen
    In: Fortschritte der Neurologie - Psychiatrie (FDN), Jg. 80, 2012, Nr. 4, S. 201 – 212
    DOI
  • Bonnet, Udo; Lensing, Maresa; Specka, Michael; Scherbaum, Norbert
    Comparison of Two Oral Symptom-triggered Pharmacological Inpatient Treatments of Acute Alcohol Withdrawal : Clomethiazole vs. Clonazepam
    In: Alcohol and Alcoholism, Jg. 46, 2011, Nr. 1, S. 68 – 73
    DOI
  • Bonnet, Udo
    Einschätzung des Abhängigkeitsrisikos von Propofol
    In: Fortschritte der Neurologie - Psychiatrie (FDN), Jg. 79, 2011, Nr. 8, S. 442 – 452
    DOI
  • Bachmann, Hagen Sjard; Lieb, B.; Bonnet, Udo; Specka, M.; Augener, S.; Siffert, Winfried; Scherbaum, Norbert
    Influence of the 393T>C Polymorphism of the GNAS1 Gene on the Intensity of Opiate Withdrawal
    In: Pharmacopsychiatry, Jg. 44, 2011, Nr. 4, S. 159 – 160
    DOI
  • Specka, Michael; Bonnet, Udo; Heilmann, Martin; Schifano, Fabrizio; Scherbaum, Norbert
    Longitudinal patterns of benzodiazepine consumption in a German cohort of methadone maintenance treatment patients
    In: Human Psychopharmacology: Clinical and Experimental, Jg. 26, 2011, Nr. 6, S. 404 – 411
    DOI
  • Bonnet, Udo; Hamzavi-Abedi, Reza; Specka, Michael; Wiltfang, Jens; Lieb, Bodo; Scherbaum, Norbert
    An open trial of gabapentin in acute alcohol withdrawal using an oral loading protocol
    In: Alcohol and Alcoholism, Jg. 45, 2010, Nr. 2, S. 143 – 145
    DOI
  • Bonnet, Udo; Scherbaum, Norbert
    Cannabisbezogene Störungen : Teil II: Psychiatrische und somatische Folgestörungen und Komorbiditäten
    In: Fortschritte der Neurologie - Psychiatrie (FDN), Jg. 78, 2010, Nr. 6, S. 360 – 370
    DOI
  • Bonnet, Udo; Scherbaum, Norbert
    Cannabisbezogene Störungen : Teil I: Pharmakologie, Epidemiologie und Therapieverfahren
    In: Fortschritte der Neurologie - Psychiatrie (FDN), Jg. 78, 2010, Nr. 5, S. 297 – 305
    DOI
  • Bonnet, Udo; Chang, D.-I.; Wiltfang, Jens; Scherbaum, Norbert; Weber, Ralph
    Manie durch Cannabis : ein Fallbericht
    In: Fortschritte der Neurologie - Psychiatrie (FDN), Jg. 78, 2010, Nr. 4, S. 223 – 225
    DOI
  • Bonnet, Udo; Bingmann, Dieter; Wiltfang, Jens; Scherbaum, Norbert; Wiemann, Martin
    Modulatory effects of neuropsychopharmaca on intracellular pH of hippocampal neurones in vitro
    In: British Journal of Pharmacology (BJP), Jg. 159, 2010, Nr. 2, S. 474 – 483
    DOI
  • Bonnet, Udo; Harkener, Jörg; Scherbaum, Norbert
    A Case Report of Propofol Dependence in a Physician
    In: Journal of Psychoactive Drugs, Jg. 40, 2008, Nr. 2, S. 215 – 217
    DOI
  • Lieb, Bodo; Rosien, M.; Bonnet, Udo; Scherbaum, Norbert
    Alkoholbezogene Störungen im Alter - Aktueller Stand zu Diagnostik und Therapie
    In: Fortschritte der Neurologie - Psychiatrie (FDN), Jg. 76, 2008, Nr. 2, S. 75 – 85
    DOI
  • Hölscher, F.; Bonnet, Udo; Scherbaum, Norbert
    Inanspruchnahmepopulation einer Cannabisambulanz
    In: Der Nervenarzt, Jg. 79, 2008, Nr. 5, S. 571 – 576
    DOI
  • Bonnet, Udo; Scherbaum, Norbert; Wiemann, Martin
    The endogenous alkaloid harmane : Acidifying and activity-reducing effects on hippocampal neurons in vitro
    In: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Jg. 32, 2008, Nr. 2, S. 362 – 367
    DOI
  • Bonnet, Udo; Wiemann, Martin
    Ammonium prepulse : Effects on intracellular pH and bioelectric activity of CA3-neurones in guinea pig hippocampal slices
    In: Brain Research, Jg. 840, 1999, Nr. 1-2, S. 16 – 22
    DOI
  • Wiemann, Martin; Schwark, Jan-Robert; Bonnet, Udo; Jansen, Hans Willi; Grinstein, Sergio; Baker, Robert E.; Lang, Hans-Jochen; Wirth, Klans; Bingmann, Dieter
    Selective inhibition of the Na⁺/H⁺ exchanger type 3 activates CO₂/H⁺-sensitive medullary neurones
    In: Pflügers Archiv: European Journal of Physiology, Jg. 438, 1999, Nr. 3, S. 255 – 262
    DOI
  • Bonnet, Udo; Banger, Markus; Leweke, F.M.; Maschke, Matthias; Kowalski, Thorsten; Gastpar, M.
    Treatment of alcohol withdrawal syndrome with Gabapentin
    In: Pharmacopsychiatry, Jg. 32, 1999, Nr. 3, S. 107 – 109
    DOI

    • Abstracts

  • Bachmann, Hagen Sjard; Liebig; Bonnet, Udo; Specka, M.; Augener, S.; Scherbaum, Norbert; Siffert, Winfried
    The T-allele of the GNB3 825C > T polymorphism is associated with increased intensity of opiate withdrawal
    8th International Sphingolipid Club Meeting, Glasgow, UK, June 30 – July 2, 2010,
    In: Naunyn-Schmiedeberg's Archives of Pharmacology. Berlin: Springer, Jg. 381, 2010, Nr. Suppl. 1, S. 87
    DOI

    • Beiträge in Sammelwerken und Tagungsbänden

  • Bonnet, Udo
    Cannabis Hyperemesis Syndrome
    In: Handbook of Cannabis and Related Pathologies: Biology, Pharmacology, Diagnosis, and Treatment / Preedy, Victor R. (Hrsg.). London, United Kingdom: Elsevier Inc., 2017, S. 466 – 470
    DOI
  • Bonnet, Udo
    Chronic Cannabis Abuse and Thyroid Function
    In: Handbook of Cannabis and Related Pathologies: Biology, Pharmacology, Diagnosis, and Treatment / Preedy, Victor R. (Hrsg.). London, United Kingdom: Elsevier Inc., 2017, S. 461 – 465
    DOI